Back to companies
Aligos Therapeutics, Inc.
ALGSUSNASDAQPharmaceuticals & HealthcareAligos Therapeutics, Inc.
Revenue
$2.2mn
YoY -39.5%
Operating income
-$88.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API